Infection and HLA-G molecules in nasal polyposis

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Rizzo, Roberta ^a   Malagutti, Nicola ^b   Bortolotti, Daria ^a   Gentili, Valentina ^a   Rotola, Antonella ^b   Fainardi, Enrico ^b   Pezzolo, Teresa ^b   Aimoni, Claudia ^b   Pelucchi, Stefano ^b   Di Luca, Dario ^a   Pastore, Antonio ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b S ANNA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR;

ADULT; AGED; ALLERGIC DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN TISSUE; IMMUNOREGULATION; INFECTION RISK; LOW RISK PATIENT; MALE; NOSE POLYP; NOSE RECONSTRUCTION; PAPILLOMAVIRUS INFECTION; POLYPOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; BIOPSY; CASE CONTROL STUDY; COMPLICATION; GENETICS; IMMUNOLOGY; INFECTION; METABOLISM; MIDDLE AGED; NASAL POLYPS; NOSE MUCOSA; PATHOLOGY; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HLA-G ANTIGENS; HUMAN PAPILLOMAVIRUS 11; HUMANS; INFECTION; INTERLEUKIN-10; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; PAPILLOMAVIRUS INFECTIONS; RECEPTORS, INTERLEUKIN-10;

EID: 84896924057     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/407430     Document Type: Article

References (36)

1. Hedman J., Kaprio J., Poussa T., Nieminen M. M., Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. International Journal of Epidemiology 1999 28 4 717 722 2-s2.0-0032814225 10.1093/ije/28.4.717 (Pubitemid 29401332)
2. Hamilos D. L., Leung D. Y. M., Wood R., Meyers A., Stephens J. K., Barkans J., Meng Q., Cunningham L., Bean D. K., Kay A. B., Hamid Q., Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. Journal of Allergy and Clinical Immunology 1993 92 1 39 48 2-s2.0-0027178693 (Pubitemid 23234081)
3. Mygind N., Nasal polyposis. Journal of Allergy and Clinical Immunology 1990 86 6 827 829 2-s2.0-0025696451 10.1016/S0091-6749(05)80142-3
4. Stierna P. L. E., Nasal polyps: relationship to infection and inflammation. Allergy and Asthma Proceedings 1996 17 5 251 257 2-s2.0-0029827095 (Pubitemid 26403405)
5. Hoffmann M., Kahn T., Goeroegh T., Lohrey C., Gottschlich S., Meyer J., Rudert H., Maune S., Tracing human papillomavirus DNA in nasal polyps by polymerase chain reaction. Acta Oto-Laryngologica 2000 120 7 872 875 2-s2.0-0034438641 10.1080/000164800750061750 (Pubitemid 32511261)
6. Zaravinos A., Bizakis J., Spandidos D. A., Prevalence of human papilloma virus and human herpes virus types 1-7 in human nasal polyposis. Journal of Medical Virology 2009 81 9 1613 1619 2-s2.0-68949160960 10.1002/jmv.21534
7. Doorbar J., Latent papillomavirus infections and their regulation. Current Opinion in Virology 2013 3 4 416 421
8. Kim D.-H., Kim E.-M., Lee E.-H., Ji K.-Y., Yi J., Park M., Kim K. D., Cho Y.-Y., Kang H.-S., Human papillomavirus 16E6 suppresses major histocompatibility complex class I by upregulating lymphotoxin expression in human cervical cancer cells. Biochemical and Biophysical Research Communications 2011 409 4 792 798 2-s2.0-79959236072 10.1016/j.bbrc.2011.05.090
9. Zhou F., Chen J., Zhao K. N., Human papillomavirus 16-encoded E7 protein inhibits IFN- γ -mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes. Journal of General Virology 2013 94 2504 2514
10. Dong D.-D., Hong Yang H. Y., Ke Li K. L., Gang Xu G. X., Song L.-H., Fan X.-L., Jiang X.-L., Yie S.-M., Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response. Reproductive Sciences 2010 17 8 718 723 2-s2.0-77954339619 10.1177/1933719110369183
11. Bortolotti D., Gentili V., Rotola A., di Luca D., Rizzo R., Implication of HLA-G 3 ′ UTR polymorphisms in Human Papillomavirus infection. Tissue Antigens 2014 83 2 113 118
12. McMaster M. T., Librach C. L., Zhou Y., Lim K.-H., Janatpour M. J., DeMars R., Kovats S., Damsky C., Fisher S. J., Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. Journal of Immunology 1995 154 8 3771 3778 2-s2.0-0028948906
13. Lefebvre S., Adrian F., Moreau P., Gourand L., Dausset J., Berrih-Aknin S., Carosella E. D., Paul P., Modulation of HLA-G expression in human thymic and amniotic epithelial cells. Human Immunology 2000 61 11 1095 1101 2-s2.0-0034509503 10.1016/S0198-8859(00)00192-0 (Pubitemid 32043885)
14. Mallet V., Fournel S., Schmitt C., Campan A., Lenfant F., Le Bouteiller P., Primary cultured human thymic epithelial cells express both membrane-bound and soluble HLA-G translated products. Journal of Reproductive Immunology 1999 43 2 225 234 2-s2.0-0032776847 10.1016/S0165-0378(99)00036-4 (Pubitemid 29349686)
15. Menier C., Rabreau M., Challier J.-C., Le Discorde M., Carosella E. D., Rouas-Freiss N., Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 2004 104 10 3153 3160 2-s2.0-8644289450 10.1182/blood-2004-03-0809 (Pubitemid 39507129)
16. Fujii T., Ishitani A., Geraghty D. E., A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. Journal of Immunology 1994 153 12 5516 5524 2-s2.0-0028116211 (Pubitemid 24377687)
17. Ishitani A., Geraghty D. E., Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proceedings of the National Academy of Sciences of the United States of America 1992 89 9 3947 3951 2-s2.0-0026575821
18. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V. M., Allan D. S. J., Makadzange A., Rowland-Jones S., Willcox B., Jones E. Y., Van Der Merwe P. A., Kumagai I., Maenaka K., Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proceedings of the National Academy of Sciences of the United States of America 2003 100 15 8856 8861 2-s2.0-0043205005 10.1073/pnas.1431057100 (Pubitemid 36899188)
19. Du L., Xiao X., Wang C., Zhang X., Zheng N., Wang L., Zhang X., Li W., Wang S., Dong Z., Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells. Cancer Science 2011 102 7 1272 1280 2-s2.0-79959217991 10.1111/j.1349-7006.2011.01951.x
20. Marchal-Bras-Goncalves R., Rouas-Freiss N., Connan F., Choppin J., Dausset J., Carosella E. D., Kirszenbaum M., Guillet J.-G., A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplantation Proceedings 2001 33 3 2355 2359 2-s2.0-0035348918 (Pubitemid 33762740)
21. Gregori S., Tomasoni D., Pacciani V., Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 2010 116 6 935 944
22. Kapasi K., Albert S. E., Yie S.-M., Zavazava N., Librach C. L., HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 2000 101 2 191 200 2-s2.0-0033779322 10.1046/j.1365-2567.2000.00109.x
23. LeMaoult J., Zafaranloo K., Le Banff C., Carosella E. D., HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB Journal 2005 19 6 662 664 2-s2.0-16344366533 10.1096/fj.04-1617fje (Pubitemid 40471278)
24. Rizzo R., Hviid T. V. F., Stignani M., Balboni A., Grappa M. T., Melchiorri L., Baricordi O. R., The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 2005 57 3-4 172 181 2-s2.0-20144374166 10.1007/s00251-005-0788-0 (Pubitemid 40775574)
25. Simões R. T., Gonçalves M. A., Castelli E. C., HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Modern Patholology 2009 22 8 1075 1082
26. Rodríguez J. A., Galeano L., Palacios D. M., Gómez C., Serrano M. L., Bravo M. M., Combita A. L., Altered HLA class i and HLA-G expression is associated with IL-10 expression in patients with cervical cancer. Pathobiology 2012 79 2 72 83 2-s2.0-84855173401 10.1159/000334089
27. Hu J., Li L., Liu Y., Overexpression of HLA-G Is positively associated with Kazakh esophageal squamous cell carcinoma in Xinjiang, China. Viral Immunology 2013 26 3 180 184
28. Yeh T.-H., Hsu W.-C., Chen Y.-S., Hsu C.-J., Lee S.-Y., Lipopolysaccharide decreases connexin 43 expression on nasal epithelial cells in vitro. Acta Oto-Laryngologica 2005 125 10 1091 1096 2-s2.0-27144518805 10.1080/00016480510037906 (Pubitemid 41510702)
29. Rizzo R., Farina I., Bortolotti D., HLA-G may predict the disease course in patients with early rheumatoid arthritis. Human Immunology 2013 74 4 425 432
30. Morandi F., Venturi C., Rizzo R., Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation. Journal of NeuroImmune Pharmacology 2013 8 4 944 955
31. Rizzo R., Bortolotti D., Fredj N. B., Role of HLA-G 14bp deletion/insertion and +3142C > G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. Human Immunology 2012 73 11 1140 1146
32. Malagutti N., Aimoni C., Balboni A., Stignani M., Melchiorri L., Borin M., Pastore A., Rizzo R., Baricordi O. R., Decreased production of human leukocyte antigen G molecules in sinonasal polyposis. American Journal of Rhinology 2008 22 5 468 473 2-s2.0-53549131699 10.2500/ajr.2008.22.3210
33. Pei F., Chen X.-P., Zhang Y., Wang Y., Chen Q., Tan X.-J., Zhang J.-F., Xue X.-C., Wu J., Qing Z.-R., Human papillomavirus infection in nasal polyps in a Chinese population. Journal of General Virology 2011 92 8 1795 1799 2-s2.0-79960361260 10.1099/vir.0.031955-0
34. DeVoti J. A., Steinberg B. M., Rosenthal D. W., Hatam L., Vambutas A., Abramson A. L., Shikowitz M. J., Bonagura V. R., Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis. Clinical and Diagnostic Laboratory Immunology 2004 11 3 538 547 2-s2.0-2442649101 10.1128/CDLI.11.3.538-547.2004 (Pubitemid 38661420)
35. Duensing S., Münger K., Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. International Journal of Cancer 2004 109 2 157 162 2-s2.0-1242319406 10.1002/ijc.11691 (Pubitemid 38240914)
36. Nguyen M. L., Nguyen M. M., Lee D., Griep A. E., Lambert P. F., The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. Journal of Virology 2003 77 12 6957 6964 2-s2.0-0038618733 10.1128/JVI.77.12.6957-6964.2003 (Pubitemid 36666888)